Sibannac, Inc.
company.status.inactiveCIK 1313938fmd_1CFBW3AJQGGF0GTVVRDG4RQJQJManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Sep 01, 2010 to Feb 28, 2017, 25 periods
| Line item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|
| Total revenues | 1 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 1 | 0 | 0 | 0 | 0 | 0 |
| Compensation and benefits | – | – | – | 0 | 0 | – |
| Operating income | – | – | – | – | (2) | (0) |
| Interest expense | (0) | 0 | 0 | – | 0 | 0 |
| Interest and investment income | – | – | – | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | 0 | (0) |
| Net income from continuing operations | – | – | – | – | (0) | (0) |
| Net income | (0) | (0) | (0) | (0) | (2) | (0) |